Format

Send to

Choose Destination
See comment in PubMed Commons below
Acta Haematol. 2006;115(1-2):28-34.

Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study.

Author information

1
Fourth Hurdle Consulting, London, UK. JuliaHutchinson@FourthHurdle.com

Abstract

Non-Hodgkin's lymphoma (NHL) is the sixth most common cancer in the United Kingdom (UK). This analysis assessed the health service costs of patients receiving chemotherapy for indolent follicular NHL based on a retrospective analysis of patient records in the UK. Each patient was followed up for a period of 3 years or until death. The analysis included 181 patients, who received a total of 187 treatment periods. Costs were estimated from the perspective of the UK National Health Service. The study found the cost of providing treatment with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) or fludarabine to patients with indolent follicular NHL to be lower than previously reported.

PMID:
16424646
DOI:
10.1159/000089462
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Support Center